Englander Institute for Precision Medicine
Credit: Shutterstock

A large prospective, randomized clinical trial in patients with advanced breast cancer has found that the use of liquid biopsy blood tests for early detection of a treatment-resistance mutation, followed by a switch to a new type of treatment, substantially extends the period of tumor control compared to standard care.

The SERENA-6 ...

Dr. Bishoy Faltas

Deep Learning Helps Predict Treatment Response in Muscle-Invasive Bladder Cancer

Dr. Olivier Elemento

Olivier Elemento, PhD, is Director of the Englander Institute for Precision Medicine and Associate Director of the Institute for Computational Biomedicine at Weill Cornell Medicine. His research group combines big data and artificial intelligence with experimentation and genomic profiling to accelerate the discovery of cancer cures. amfAR VP and Director of Research Andrea Gramatica, PhD, spoke with Dr. Elemento about his work and its potential applications in HIV research....